Literature DB >> 10047639

Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.

H Tomiyama1, T Nakayama, G Watanabe, K Shiojima, Y Sakuma, A Yamamoto, Y Imai, H Yoshida, N Doba.   

Abstract

BACKGROUND: We investigated the effects of a short-acting loop diuretic (furosemide) and a long-acting loop diuretic (azosemide) on heart rate variability, fluid balance, and neurohormonal responses in patients with mild to moderate chronic congestive heart failure.
METHODS: Nineteen patients with mild to moderate chronic congestive heart failure received furosemide (40 to 60 mg/day) or azosemide (60 to 90 mg/day) for 5 days in a crossover manner. We performed time-domain and frequency-domain analyses of 24-hour Holter electrocardiographic recordings to assess heart rate variability.
RESULTS: The 24-hour urinary sodium excretion was similar during the furosemide and azosemide treatment periods but was significantly greater in the first 2 hours after drug administration during furosemide treatment. Plasma renin activity and the hematocrit level increased and high-frequency power significantly decreased 2 hours after the administration of furosemide only. The standard deviation of all normal R-R intervals and the root mean square of successive differences in the R-R interval were lower with furosemide than with azosemide (P <.05).
CONCLUSIONS: Furosemide, a short-acting loop diuretic, has a greater influence on heart rate variability and fluid balance than azosemide, a long-acting loop diuretic, in patients with mild to moderate chronic congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10047639     DOI: 10.1016/s0002-8703(99)70504-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

Review 1.  Pharmacologic modulation of parasympathetic activity in heart failure.

Authors:  Monali Y Desai; Mari A Watanabe; Abhay A Laddu; Paul J Hauptman
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

Review 2.  Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve?

Authors:  N Doba; H Tomiyama; T Nakayama
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

3.  Heart rate variability as a biomarker in patients with Chronic Chagas Cardiomyopathy with or without concomitant digestive involvement and its relationship with the Rassi score.

Authors:  Luiz Eduardo Virgilio Silva; Henrique Turin Moreira; Marina Madureira de Oliveira; Lorena Sayore Suzumura Cintra; Helio Cesar Salgado; Rubens Fazan; Renato Tinós; Anis Rassi; André Schmidt; J Antônio Marin-Neto
Journal:  Biomed Eng Online       Date:  2022-06-28       Impact factor: 3.903

Review 4.  Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials.

Authors:  Peter Samuel Eid; Doaa Alaa Ibrahim; Ahmad Helmy Zayan; Manal Mahmoud Abd Elrahman; Mostafa Ahmed Abdo Shehata; Hend Kandil; Mahmoud Ahmed Abouibrahim; Luc Minh Duy; Ashraf Shinkar; Muhammed Khaled Elfaituri; Le Huu Nhat Minh; Mostafa Mahmoud Fahmy; Dao Ngoc Hien Tam; Nguyen Lam Vuong; Jaffer Shah; Van Buu Dan Do; Kenji Hirayama; Nguyen Tien Huy
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.